In Vitro Activity of Diphenyleneiodonium toward Multidrug-Resistant Helicobacter pylori Strains
- Authors
- Chung, Jun-Won; Kim, Su Young; Park, Hee Jung; Chung, Chang Su; Lee, Hee Woo; Lee, Sun Mi; Kim, Inki; Pak, Jhang Ho; Lee, Gin Hyug; Jeong, Jin-Yong
- Issue Date
- Sep-2017
- Publisher
- EDITORIAL OFFICE GUT & LIVER
- Keywords
- Helicobacter pylori; Diphenyleneiodonium; Drug resistance, multiple; Anti-bacterial agents; Minimal inhibitory concentration
- Citation
- GUT AND LIVER, v.11, no.5, pp.648 - 654
- Journal Title
- GUT AND LIVER
- Volume
- 11
- Number
- 5
- Start Page
- 648
- End Page
- 654
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5779
- DOI
- 10.5009/gnl16503
- ISSN
- 1976-2283
- Abstract
- Background/Aims: The increased resistance of Helicobacter pylori to antibiotics has increased the need to develop new treatments for this bacterium. The aim of our study was to identify new drugs with anti-H. pylori activity. Methods: We screened a small molecule library the library of pharmacologically active compounds (LOPAC), which includes 1,280 pharmacologically active compounds to identify inhibitors of H. pylori growth. The minimal inhibitory concentrations (MICs) of antibiotics against multidrug-resistant H. pylori strains were determined using the agar dilution method. Results: We identified diphenyleneiodonium (DPI) as a novel anti H. pylori agent. The MIC values for DPI were <0.03 mu g/mL against all tested H. pylori strains. DPI also exhibited strong antibacterial activity against common gram-negative and gram-positive pathogenic bacteria. Conclusions: DPI may be a candidate anti-H. pylori drug for future development.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 의과대학 > 의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.